These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3839529)

  • 21. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
    Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
    Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bayesian estimation of doxorubicin pharmacokinetic parameters.
    Bressolle F; Ray P; Jacquet JM; Brès J; Galtier M; Donadio D; Jourdan J; Rossi JF
    Cancer Chemother Pharmacol; 1991; 29(1):53-60. PubMed ID: 1742849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy.
    Dupuis C; Mercier C; Yang C; Monjanel-Mouterde S; Ciccolini J; Fanciullino R; Pourroy B; Deville JL; Duffaud F; Bagarry-Liegey D; Durand A; Iliadis A; Favre R
    Anticancer Drugs; 2008 Mar; 19(3):267-73. PubMed ID: 18510172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High dose methotrexate population pharmacokinetics and Bayesian estimation in patients with lymphoid malignancy.
    Min Y; Qiang F; Peng L; Zhu Z
    Biopharm Drug Dispos; 2009 Nov; 30(8):437-47. PubMed ID: 19746402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptive control methods for the dose individualisation of anticancer agents.
    Rousseau A; Marquet P; Debord J; Sabot C; Lachâtre G
    Clin Pharmacokinet; 2000 Apr; 38(4):315-53. PubMed ID: 10803455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer.
    Jodrell DI; Reyno LM; Sridhara R; Eisenberger MA; Tkaczuk KH; Zuhowski EG; Sinibaldi VJ; Novak MJ; Egorin MJ
    J Clin Oncol; 1994 Jan; 12(1):166-75. PubMed ID: 8270974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. External evaluation and systematic review of population pharmacokinetic models for high-dose methotrexate in cancer patients.
    Yang Y; Wang C; Chen Y; Wang X; Jiao Z; Wang Z
    Eur J Pharm Sci; 2023 Jul; 186():106416. PubMed ID: 37119861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate test-dose protocol in the presence of 7-hydroxy-methotrexate.
    Lena N; Imbert AM; Favre R; Cano JP; Carcassonne Y
    Eur J Cancer Clin Oncol; 1987 May; 23(5):481-5. PubMed ID: 3477455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits.
    Iven H; Brasch H; Engster J
    Cancer Chemother Pharmacol; 1985; 15(2):115-20. PubMed ID: 4017160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of patients with impaired hepatic drug metabolism using a limited sampling procedure for estimation of phenazone (antipyrine) pharmacokinetic parameters.
    Fabre D; Bressolle F; Goméni R; Bouvet O; Dubois A; Raffanel C; Gris JC; Galtier M
    Clin Pharmacokinet; 1993 Apr; 24(4):333-43. PubMed ID: 8491059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computer-assisted drug assay interpretation based on Bayesian estimation of individual pharmacokinetics: application to lidocaine.
    Vozeh S; Hillman R; Wandell M; Ludden T; Sheiner L
    Ther Drug Monit; 1985; 7(1):66-73. PubMed ID: 3838832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of biological variables upon pharmacokinetic parameters of intramuscular methotrexate in rheumatoid arthritis.
    Debord J; Carpentier N; Sabot C; Bertin P; Marquet P; Treves R; Merle L; Lachâtre G
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):227-30. PubMed ID: 9587050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package.
    Gomeni R; Pineau G; Mentré F
    Anticancer Res; 1994; 14(6A):2321-6. PubMed ID: 7825966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of high-dose methotrexate in adult osteogenic sarcoma.
    Pignon T; Lacarelle B; Duffaud F; Guillet P; Catalin J; Durand A; Monjanel S; Favre R
    Cancer Chemother Pharmacol; 1994; 33(5):420-4. PubMed ID: 8306417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A limited sampling method to estimate methotrexate pharmacokinetics in patients with rheumatoid arthritis using a Bayesian approach and the population data modeling program P-PHARM.
    Bressolle F; Bologna C; Edno L; Bernard JC; Gomeni R; Sany J; Combe B
    Eur J Clin Pharmacol; 1996; 49(4):285-92. PubMed ID: 8857074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pharmacokinetic model for high-dose methotrexate infusions in man.
    Reich SD; Bachur NR; Goebel RH; Berman M
    J Pharmacokinet Biopharm; 1977 Oct; 5(5):421-33. PubMed ID: 925879
    [No Abstract]   [Full Text] [Related]  

  • 37. A randomized comparison of high-dose infusion methotrexate versus standard-dose weekly therapy in head and neck squamous cancer.
    Taylor SG; McGuire WP; Hauck WW; Showel JL; Lad TE
    J Clin Oncol; 1984 Sep; 2(9):1006-11. PubMed ID: 6332178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the estimation of midazolam concentrations and pharmacokinetic parameters in intensive care patients using a bayesian pharmacokinetic software (PKS) according to sparse sampling approach.
    Bolon M; Bastien O; Flamens C; Paulus S; Salord F; Boulieu R
    J Pharm Pharmacol; 2003 Jun; 55(6):765-71. PubMed ID: 12841936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A limited sampling procedure for estimating adriamycin pharmacokinetics in cancer patients.
    Launay MC; Milano G; Iliadis A; Frenay M; Namer N
    Br J Cancer; 1989 Jul; 60(1):89-92. PubMed ID: 2803920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mathematical modeling -- guide to high-dose methotrexate infusion therapy.
    Reich SD
    Cancer Chemother Pharmacol; 1979; 3(1):25-31. PubMed ID: 535126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.